DSM — Stock Film
STOCK FILMSCENE 1/11DSM · $6.00
Stock Expert AI presents
DSM
BNY Mellon Strategic Municipal Bond Fund, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
BNY Mellon Strategic Municipal Bond Fund, Inc. A quick introduction.

On the stock market since 1989, it operates in the world of money and finance. It has 29,000 employees. Now — the numbers.

on the stock market since 1989
29K employees
$296.6M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.3.

The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales are moving sideways.

No real growth (-2% a year). Red columns mark years that ended in a loss.

$21.8M
2021
-$68.4M
2022
$5M
2023
$40M
2024
$20.1M
2025
In the vault right now:
$0
DEBT: $167.1M
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
23
very weak

Clearly below the class average.

FINANCIAL STRENGTH
65
strong

For a bank, strength is measured by capital buffers and reserves — not cash minus debt.

VALUATION
80
very strong

The price looks reasonable next to what the company earns.

GROWTH
6
very weak

Clearly below the class average.

PRICE MOMENTUM
57
average

The price is looking for direction — no strong breakout, no collapse.

WORTH WATCHING

Growth: Sales growth trails the sector average.

Business Quality: Profit power and business quality trail similar companies in the sector.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
Growth has stalled2/10
Costs eat into the margin4/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 30% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/3
The product is selling

Sales run at $20.1M a year. A small number, but proof the product has real buyers.

2
THE BRIGHT SIDE · 2/3
Executives are buying their own stock

Over the last 12 months, company executives reported 4 buys and 1 sell. Management buying with its own money is usually read as a good sign.

3
THE BRIGHT SIDE · 3/3
Pays a steady dividend

It pays out $0.30 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/2
Small sales, big loss

A loss of $5.5M against $20.1M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
F
0 / 100 · MoonshotScore

On our five-subject report card, DSM sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: DSM is a high-risk stock — not yet profitable, and its future rides on its product catching on.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film